Steroid avoidance in renal transplantation

Current Opinion in Organ Transplantation

Volumn 16, Issue 5, 2011, Pages 477-482

  Lightner, Amy ^a   Concepcion, Waldo ^a   Grimm, Paul ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Immunosuppression; pediatric renal transplantation; steroid avoidance

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; DACLIZUMAB; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADOLESCENT; ARTICLE; BK VIRUS; BODY HEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL PROTOCOL; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DRUG SAFETY; GRAFT RECIPIENT; GRAFT SURVIVAL; GROWTH; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; PATIENT SELECTION; RISK FACTOR; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; VIREMIA;

GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PROGNOSIS; STEROIDS;

EID: 80052658469     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32834a8c74     Document Type: Article

References (41)

1. Delucchi A, Valenzuela M, Ferrario M, et al. Early steroid withdrawal in pediatric renal transplant on newer immunosuppressive drugs. Pediatr Transplant 2007; 11:743-748. (Pubitemid 47512316)
2. Lerut JP. Avoiding steroids in solid organ transplantation. Transpl Int 2003; 16:213-224. (Pubitemid 36682178)
3. Birkeland SA, Larsen KE, Rohr N. Pediatric renal transplantation without steroids. Pediatr Nephrol 1998; 12:87-92. (Pubitemid 28165792)
4. Birkeland SA, Andersen HK, Hamilton-Dutoit SJ. Preventing acute rejection, Epstein-Barr virus infection, and posttransplant lymphoproliferative disorders after kidney transplantation: use of aciclovir and mycophenolate mofetil in a steroid-free immunosuppressive protocol. Transplantation 1999; 67:1209-1214. (Pubitemid 29239469)
5. Sartori TM, Maurizio PG, Sara P, et al. Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation. J Heart Lung Transplant 1999; 18:693-700. (Pubitemid 29362005)
6. Fine RN, Martz K, Stablein D. What have 20 years of data from the North American Pediatric Renal Transplant Cooperative Study taught us about growth following renal transplantation in infants, children, and adolescents with end-stage renal disease? Pediatr Nephrol 2010; 25:739-746.
7. Seikaly M, Ho PL, Emmett L, Tejani A. The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: renal transplantation from 1987 through 1998. Pediatr Transplant 2001; 5:215-231. (Pubitemid 32545270)
8. Ahsan N, Hricik D, Matas A, et al. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil: a prospective randomized study. Steroid Withdrawal Study Group. Transplantation 1999; 68:1865-1874. (Pubitemid 30027339)
9. Roberti I, Reisman L, Lieberman KV, Burrows L. Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up). Clin Transplant 1994; 8:405-408. (Pubitemid 24236278)
10. Hricik DE, O'Toole MA, Schulak JA, Herson J. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 1993; 4:1300-1305.
11. Kasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000; 11:1910-1917.
12. Pascual J, Quereda C, Zamora J, Hernandez D. Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials. Transplantation 2004; 78:1548-1556. (Pubitemid 39552943)
13. Schulak JA, Hricik DE. Steroid withdrawal after renal transplantation. Clin Transplant 1994; 8 (2 Pt 2):211-216. (Pubitemid 24105417)
14. Kasiske BL, Chakkera H, Louis T, Ma JZ. Immunosuppression withdrawal in renal transplantation. Transplant Proc 2000; 32:1506-1507.
15. Almawi WY, Hess DA, Assi JW, et al. Pretreatment with glucocorticoids enhances T-cell effector function: possible implication for immune rebound accompanying glucocorticoid withdrawal. Cell Transplant 1999; 8:637-647. (Pubitemid 30111438)
16. Pascual J, Zamora J, Galeano C, et al. Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev 2009:CD005632.
17. Walczak DA, Calvert D, Jarzembowski TM, et al. Increased risk of posttransplant diabetes mellitus despite early steroid discontinuation in Hispanic kidney transplant recipients. Clin Transplant 2005; 19:527-531. (Pubitemid 40990665)
18. Chavers BM, Chang YC, Gillingham KJ, Matas A. Pediatric kidney transplantation using a novel protocol of rapid (6-day) discontinuation of prednisone: 2-year results. Transplantation 2009; 88:237-241.
19. Grenda R, Watson A, Trompeter R, et al. A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study. Am J Transplant 2010; 10:828-836.
20. Laan RF, van Riel PL, van de Putte LB, et al. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis: a randomized, controlled study. Ann Intern Med 1993; 119:963-968. (Pubitemid 23334651)
21. Ruegsegger P, Medici TC, Anliker M. Corticosteroid-induced bone loss: a longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 1983; 25:615-620. (Pubitemid 14211628)
22. Birkeland SA. Steroid-free immunosuppression in renal transplantation. Lancet 1996; 348:1105-1106.
23. Birkeland SA. Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients. Transplantation 2001; 71:1089-1090.
24. Li L, Chaudhuri A, Chen A, et al. Efficacy and safety of thymoglobulin induction as an alternative approach for steroid-free maintenance immunosuppression in pediatric renal transplantation. Transplantation 2010; 90:1516-1520.
25. Sarwal MM, Vidhun JR, Alexander SR, et al. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 2003; 76:1331-1339. (Pubitemid 37430720)
26. Sarwal MM, Yorgin PD, Alexander S, et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001; 72:13-21. (Pubitemid 32652500)
27. Grenda R, Webb NJ. Steroid minimization in pediatric renal transplantation: early withdrawal or avoidance? Pediatr Transplant 2010; 14:961-967.
28. Li L, Chang A, Naesens M, et al. Steroid-free immunosuppression since 1999 pediatric renal transplants with sustained graft and patient benefits. Am J Transplant 2009; 9:1362-1372.
29. Li L, Concepcion W, Salvatierra O, Sarwal M. One year results of a prospective, randomized, multicenter trial of steroid avoidance in pediatric renal transplantation. ITPA Congress: Istanbul, Turkey; 2009.
30. Iorember FM, Patel HP, Ohana A, et al. Steroid avoidance using sirolimus and cyclosporine in pediatric renal transplantation: one year analysis. Pediatr Transplant 2010; 14:93-99.
31. Thomas PG, Woodside KJ, Lappin JA, et al. Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation. Transplantation 2007; 83:1509-1512. (Pubitemid 46934076)
32. Sutherland S, Li L, Concepcion W, et al. Steroid-free immunosuppression in pediatric renal transplantation: rationale for and [corrected] outcomes following conversion to steroid-based therapy. Transplantation 2009; 87:1744-1748.
33. Shapiro R, Ellis D, Tan HP, et al. Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr 2006; 148:813-818. (Pubitemid 43870082)
34. Tan HP, Donaldson J, Ellis D, et al. Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience. Transplantation 2008; 86:1725-1731.
35. Bhakta N, Marik J, Malekzadeh M, et al. Can pediatric steroid-free renal transplantation improve growth and metabolic complications? Pediatr Transplant 2008; 12:854-861.
36. Silverstein DM, Aviles DH, LeBlanc PM, et al. Results of one-year follow-up of steroid-free immunosuppression in pediatric renal transplant patients. Pediatr Transplant 2005; 9:589-597. (Pubitemid 41413497)
37. McDonald RA, Smith JM, Ho M, et al. Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. Am J Transplant 2008; 8:984-989. (Pubitemid 351537758)
38. Grenda R. Effects of steroid avoidance and novel protocols on growth in paediatric renal transplant patients. Pediatr Nephrol 2010; 25:747-752.
39. Mehls O, Wilton P, Lilien M, et al. Does growth hormone treatment affect the risk of posttransplant renal cancer? Pediatr Nephrol 2002; 17:984-989. (Pubitemid 36097639)
40. Dharnidharka VR, Talley LI, Martz KL, et al. Recombinant growth hormone use pretransplant and risk for posttransplant lymphoproliferative disease: a report of the NAPRTCS. Pediatr Transplant 2008; 12:689-695.
41. Child CJ, Zimmermann AG, Scott RS, et al. Prevalence and incidence of diabetes mellitus in GH-treated children and adolescents: analysis from the GeNeSIS Observational Research Program. J Clin Endocrinol Metab 2011; 96:E1025-E1034.